Evid Invest
Holders — by stockHoldings — by fund

ACORN CAPITAL ADVISORS, LLC

Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0002054410

$364.0M

disclosed book value

22

positions

22%

largest position share

Positions, as of 2026-09-30

top 22 of 22 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1CGONCG ONCOLOGY INC1.1M$80.2M22%
2URGNUROGEN PHARMA LTD1.6M$67.0M18.4%
3PBYIPUMA BIOTECHNOLOGY INC4.1M$41.0M11.3%
4CADLCANDEL THERAPEUTICS INC3.5M$36.5M10%
5TRVITREVI THERAPEUTICS INC2.1M$30.7M8.4%
6HELPHELUS PHARMA INC.1.5M$18.9M5.2%
7JBIOJADE BIOSCEINCES INC986,760$13.9M3.8%
8BCAXBICARA THERAPEUTICS668,381$12.4M3.4%
9VSTMVERASTEM INC1.5M$11.8M3.2%
10OKURONKURE THERAPEUTICS INC2.8M$7.8M2.1%
11ENGNEUGENE THERAPEUTICS3.8M$7.6M2.1%
12ANTXAN2 THERAPEUTICS1.3M$6.9M1.9%
13AURAAURA BIOSCIENCES INC1.0M$6.4M1.8%
14TARAPROTARA THERAPEUTICS INC1.8M$5.3M1.5%
15ANNXANNEXON INC.1.1M$4.8M1.3%
16LONALEONABIO, INC.1.1M$4.1M1.1%
17WHWKWHITEHAWK THERAPEUTICS INC932,139$3.5M1%
18QTTBQ32 BIO INC.216,171$1.8M0.5%
19KPTIKARYOPHARM THERAPEUTICS INC1.2M$1.5M0.4%
20JSPRJASPER THERAPEUTICS1.4M$834,1320.2%
21MNLOUSDYARROW BIOSCIENCES INC32,005$720,7440.2%
22BCABGBPBIOATLA INC108,127$140,5650%

Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.